Wang C et al / Acta Pharmacol Sin 2004 Jan; 25 (1): 35-40
B
and tumor necrosis factor-
expression
in ischemia-reperfusion hearts1
Chi WANG,Tian-hui CHANG2, Xin-hua ZHANG, Huai-liang WANG
Department of Clinical Pharmacology, China Medical University, Shengyang 110001, China
1 Project partly supported by the Key Foundation of the Ministry of Public Health of China, No 88402257.
2 Correspondence to Prof Tian-hui CHANG. Phn 86-24-2325-6666, ext 5130 or 5547. E-mail thchang99@yahoo.com.cn
Received 2002-11-26 Accepted 2003-05-02
KEY WORDS dl-praeruptorin A; myocardial; ischemia; reperfusion
injury; nucleus factor-
B; tumor
necrosis factor-
ABSTRACT
AIM: To study the effects of dl-praeruptorin A (Pd-Ia) on nucleus
factor-
B (NF-
B)
activativity and tumor necrosis factor-
(TNF-
) expression in ischemia-reperfusion
(I/R) myocardium. METHODS: Langendorff's isolated rat heart was subjected
to a 10-min ischemia followed by a 30-min reperfusion. NF-
B
activity in nucleus was analyzed by Sandwich Enzyme-Linked Immunosorbent Assay
(ELISA). TNF-
level in cytoplasm
was measured by radioimmunoassay. Infiltration of neutrophils was observed using
Hematoxylin-Eosin staining under optical microscope. RESULTS: Pd-Ia 1.0
µmol/L with 30-min preventive perfusion decreased NF-
B
activity from
0.98±0.13 to 0.65±0.17 (P<0.05 vs solvent) and down-regulated
TNF-
expression from 13.7±6.1
µg/L to
9.4±2.7 µg/L (P<0.01 vs solvent) under conditions
with increase of coronary flow, negative inotropic action, inhibition of creatine
kinase and without chronotropic action, whereas, infiltration of neutrophils
was mild. CONCLUSION: Pd-Ia inhibited NF-
B
activativity in I/R myocardium and led to down-regulation of TNF-
expression, which might be one of molecular mechanisms of Pd-Ia in cardioprotection.
INTRODUCTION
Ischemia-reperfusion (I/R) injury commonly occured during thrombolytic therapy for myocardial
infarction, restoration of blood flow after cardioplegic
arrest in cardiovascular surgery, and heart trans-plantation. It was a complicated pathophysiological
process, involving in calcium overload, free radical
production, metabolic abnormalities, and inflammatory
reaction, etc. Along with development of modern
molecular biology, the expression and regulation of gene in
myocardium I/R injury were focused on nuclear transcription
factor-
B (NF-
B) and inhibitory
B (I
B)[1-4].
NF-
B belongs to a rel/NF-
B
protein family and found primarily in immune, inflammation, and cellar defenses,
which played very important roles in regulating multiple immediate-early gene
expressions. The reasons were probably related to impact on the process of inflammatory
reaction, cellular apoptosis and necrosis, ischemic preconditioning, and ventricular
remodeling, etc, especially involved in positive and negative feedback,
and cross-regulation in NF-
B activation[5-9].
However, the exact mechanism was unclear, thus, it is necessary to further explore
the molecular mechanisms of NF-
B
activation in myocardial I/R injury.
Tumor necrosis factor-
(TNF-
), an important inflammatory cytokine, was regulated by
NF-
B and counteracted on
NF-
B activation[10]. Sometimes, improper activation of
NF-
B could induce excessive inflammatory responses and
injury. Therefore, modulation of NF-
B
activation might dedicate a new target in alleviation of
myocardium I/R injury[11-13].
Our previous studies had proved that dl-praeruptorin A (Pd-Ia), a
Ca2+-influx blocker[14-16] and
K+-channel opener[17], isolated from a traditional
Chinese medicine "Baihua Qianhu", had cardioprotective
effects and relieved inflammatory reaction and apoptosis
in I/R myocardium through inhibition of interleukin-6
(IL-6) and Fas, bax, bcl-2 protein
expression[18]. However, the effects of Pd-Ia on
NF-
B activation and TNF-
expression in I/R myocardium
had not been investigated. In the present study, the
influences of Pd-Ia on these two factors were firstly
observed and aimed to offer a new target of therapy
for ischemic disease.
MATERIALS AND METHODS
Drugs and reagents Pd-Ia extracted from the
root of Peucedanum praeruptorum Dunn, were provided
by Prof OKUYAMA T (Department of Pharmacognosy and Phytochemistry, Meiji College of Pharmacy,
Tokyo 154, Japan), diltiazem (Fanabe Seiyaku), goat
polyclonal IgG of NF-
B p65 and rabbit polyclonal IgG of
NF-
B p65 (Santa Cruz, USA), goat antirabbit HRP-IgG (HuaMei, China), 96-well
microti-er plates (Costar, USA), TNF-
radioimmunoassay kit (Chinese Atomic Energy Research
Institute, China), LDH, and CK assay kits (Jian Cheng
Biology Research Institute, Nanjing) were used in this
study.
Heart perfusion Thirty-five Wistar rats (200-400 g, Grade II, Certificate No 0001) of both sexes supplied by Laboratory Animal Center of China Medical University were divided randomly into 5 groups: sham, solvent, diltiazem 1.2 µmol/L, Pd-Ia 0.2 µmol/L, Pd-Ia 1.0 µmol/L, and Pd-Ia 3.0 µmol/L, respectively. All experiments were performed in accordance with Guidelines for Animal Experimentation established by the Center of Liaoning Experimental Animal Administration.
Langendorff's isolated perfused heart was performed as follows[19]: perfused pressure, 47.8 mmHg; Krebs-Henseleit solution [(in mmol/L) NaCl 119, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, and glucose 10 (pH 7.4)] warmed at 38 ºC by circulated water from the thermostat and equilibrated with 95 % O2/5 % CO2. After equilibrium for 15-30 min (reached to stable conditions), the heart was perfused with drug solutions firstly for 30 min, and then, subjected to a 10-min ischemia followed by a 30-min reper-fusion. Meanwhile, myocardial contraction (MC), heart rate (HR) and coronary flow (CF) were examined before ischemia and 10, 20, and 30 min after reperfusion, respectively. The activities of lactate dehydrogenase (LDH) and creatine kinase (CK) were detected through the perfusion fluids collected. Left ventricles wraped with tin foil paper were frozen in liquid nitrogen immediately at the end of experiment. All accumulated myocardial samples were preserved in -85 ºC superlow temperature refrigerator for the purposes of future wax section preparation and protein isolation.
Isolation of proteins in nucleus and cytoplasm About 0.1 g myocardial samples plus 0.8 mL ice-cold hypotonic buffer A [HEPES 10 mmol/L, pH 7.9, KCl 10 mmol/L, edetic acid 0.1 mmol/L, dithiothreitol (DTT) 1 mmol/L, protease inhibitor phenylmethylsulfonyl fluoride (PMSF) 0.5 mmol/L, and phosphatase inhibitor NaF 50 mmol/L], were homogenized. The homogenates were centrifuged (15 min, 100×g, 4 ºC) in order to eliminate unbroken tissue. After ice-incubation for 20 min, the supernatants were vortexed for 30 s and centrifuged (15 min, 5000×g, 4 ºC). Supernatants containing cytoplasmic proteins were stored at -85 ºC. The remainder were mixed with ice-cold hypertonic salt buffer B (the same as buffer A mentioned above, but NaCl 0.4 mol/L replaced KCl 10 mmol/L). After adding 10 % nonidet P-40, 50 µL, it was ice-incubated for 20 min and centrifuged (15 min, 14 000×g, 4 ºC). Then, the nuclear proteins in supernatants were obtained and stored at -85 ºC. The total proteins were determined by Coomassie blue staining assay.
Sandwich enzyme-linked immunosorbent assay (ELISA) The 96-well microti-er
plates were coated with goat polyclonal IgG of NF-
B
p65 (1:500, 100 µL per well, 4 ºC) for a night. Next morning, after
washing three times with PBS, the plates were filled with bovine serum albumin
0.6 mmol/L (100 µL per well) and stayed at 4 ºC passing the night
again. After the plate washing, the test samples (1:50) were added and incubated
at 37 ºC for 2 h (the same as belows), then, rabbit polyclonal IgG of NF-
B
p65 (1:500) and sheep anti-rabbit HRP-IgG (1:1000) were added, respectively.
Finally, substrate enzyme OPD 2.0 mmol/L (containing 0.006 % H2O2)
were added and incubated for 1 h, and citric acid 2.0 mol/L (50 µL per
well ) was added to end the reaction. NF-
B
was evaluated with absorbance (A) value detected by microplate photometer
at
450 nm[20].
Radioimmunoassay Cytoplasmic
TNF-
was measured according to instruction.
Pathologic observation Myocardium was stained by Hematoxylin-Eosin's method, and infiltration of inflammatory cells was observed under optics microscope.
Statistical analysis All data were expressed as
mean±SD. One-way ANOVA analysis was used by SPSS software to assess statistical significance between
drug groups and various related control groups.
P<0.05 was considered to be significant. The relationship
between TNF-
and NF-
B was estimated
by correlation analysis.
RESULTS
Effects on cardiohemodynamics Pd-Ia (0.2, 1.0, and 3.0 µmol/L) dose-dependently decreased MC (P<0.05 vs solvent), and the mean inhibitory rates were 33 %±20 %, 55 %±20 % and 57 %±30 %, respectively. Also Pd-Ia reduced HR slightly, but there was no statistic significance (P>0.05). Pd-Ia expressed a dual action to CF, it increased CF at lower dose (0.2 µmol/L), but decreased it at higher dose (3.0 µmol/L), (P<0.05 vs solvent). Diltiazem had similar cardiohemodynamic effects to Pd-Ia (0.2 µmol/L), but its inhibition on HR was markedly significant compared with Pd-Ia, the mean inhibitory rate reached to 45 %±26 % (P<0.01 vs sham, Tab 1).
Tab 1. Effects of Pd-Ia on cardiohemodynamics in isolated rat hearts subjected to a 10-min ischemia followed by a 30-min reperfusion. Mean±SD. bP<0.05, cP<0.01 vs sham. eP<0.05, fP<0.01 vs Sol.
Sham: sham control; Sol: solvent control; Dil: diltiazem control; Pd-Ia: dl-praeruptorin A group; n: number of rats; Conc: concentration; MC: myocardial contraction/cm; HR: heart rate/bpm; CF: coronary flow/mL×min-1.
Effects on NF-
B activity Pd-Ia
in all three doses decreased NF-
B
activity markedly, for example, at doses of 0.2 and 1.0 µmol/L, NF-
B
activity was inhibited from 0.98±0.13 to 0.60±0.14 and 0.65±0.17,
respectively (P<0.05 vs solvent). Diltiazem had the similar
effect to Pd-Ia, the activity was inhibited from
1.3±0.6 to 1.01±0.14 (P<0.05 vs sham), but it seemed
weak in potency compared with Pd-Ia.
Effects on TNF-
expression
Pd-Ia (1.0 µmol/L, 3.0 µmol/L) decreased TNF-
from (13.7±6.1) µg/L to (9.4±2.7) µg/L and (10.3±2.2)
µg/L, respectively (P<0.01 vs solvent). However, diltiazem
had no significant changes on TNF-
(P>0.05 vs sham).
Effects on LDH and CK There was no difference in LDH between Pd-Ia groups and controls. However, at reperfusion 20 min, Pd-Ia (1.0 and 3.0 µmol/L) dose-dependently decreased CK from (73±16) kU/L to (34±6) kU/L (P<0.05 vs sham) and (24±4) kU/L, respectively (P<0.01 vs sham, Tab 2).
Tab 2. Effects of Pd-Ia on LDH and CK in isolated hearts of rat subjected to a 10-min ischemia followed by a 30-min reperfusion. n=3. Mean±SD. bP<0.05, cP<0.01 vs Sham. eP<0.05, fP<0.01 vs Sol.
Conc: concentration; Sham: sham control; Sol: solvent control; Dil: diltiazem control; Pd-Ia: dl-praeruptorin A group; n: number of rats; LDH: lactate dehydrogenase/U×L-1; CK: creatine kinase/kU×L-1.
Correlation analysis between NF-
B
activity and TNF-
expression There
existed a linearity and positive correlation between NF-
B
activity and TNF-
expression.
The correlation coefficients (r) were 0.65 in solvent control and Pd-Ia
group (1.0 µmol/L), respectively (Fig 2).
Fig 2. Correlativity analysis between NF-
B
activity and TNF-
expression in
solvent and Pd-Ia 1.0 µmol/L group during myocardial ischemia-reperfusion
in isolated rat hearts. The correlation coefficients (r) were 0.65 respectivly.
Pd-Ia: dl-praeruptorin A; NF-
B:
nuclear factor-
B; TNF-
:
tumor necrosis factor-
.
Effects on infiltration of inflammatory cells In controls, serious neutrophil infiltration was observed, and most nucleolus of neutrophils staining in blue or violet, or more seen indicates inflammatory cell infiltration, whereas, in Pd-Ia and diltiazem groups, they were alleviated markedly (Fig 3).
Fig 3. Micrograph demonstrating inflammatory cell infiltration in left ventricular myocardium subjected to a 10-min ischemia followed by a 30-min reperfusion in isolated rat hearts treated with a 30-min preventive perfusion of Pd-Ia 3.0 µmol/L (B) or K-H solution (A). ×400.
DISCUSSION
In this experiments, we found that Pd-Ia inhibited NF-
B
activity in nucleus and led to down-regulation of TNF-
expression in cytoplasm under conditions with increase of CF, negative inotropic
action, and without chronotropic action. Also it relieved infiltration of neutrophils
and lowered CK, all these would be benefical to cardioprotection in myocardial
I/R injury and corresponded with previous studies[21,22].
It is well-known that modulation of NF-
B
activity can prevent myocardial I/R injury. NF-
B
exists as a latent cytoplasmic complex bound to I
B,
an inhibitory molecule to inhibit NF-
B
nuclear localization and DNA binding. Five I
B
isoforms are I
B-
,
I
B-
,
I
B-
,
I
B-
,
and I
B-
,
respectively. Among them, I
B-
phosphorylation could lead to an immediate NF-
B
activation, but I
B-
was involved in a slow and persistent activation of NF-
B,
suggesting that I
B-
might occurred in acute activation of NF-
B.
Conver-sely, the activation of NF-
B
could promote I
B-
gene expression. Thus, the inhibition of NF-
B
mainly have two pathways: (1) inhibiting I
B-
kinase activity to limit I
B-
phosphorylation and NF-
B activation[23];
and (2) inducing I
B-
gene expression. In this way, new-synthesized I
B-
would rapidly supply the depletion of I
B-
in cytoplasm in order to remodel NF-
B
complexes[24, 25]. Pd-Ia inhibiting NF-
B
activation was probably involved in such two pathways, so it is necessary and
valuable to explore further in these fields.
In addition, Pd-Ia reduced TNF-
over-expression in I/R myocardium, and there was a positive correlation between
NF-
B activity and TNF-
expression, suggesting that activation of NF-
B
might play important roles in up-regulation of TNF-
mRNA level and enhancement of TNF-
.
In conclusion, Pd-Ia attenuated NF-
B
activity in nucleus and TNF-
expression
in cytoplasm, this might be one of its molecular mechanisms in cardioprotection.
It displays a bright prospects in prevention and therapy of ischemic heart diseases
and development of a new target of medicines for treatment of ischemic disease
in future.
ACKNOWLEDGMENT We would especially thank to Experimental Center of China Medical University for expert technical assistances.
REFERENCES
B
and I
B protein: new discoveries
and insights. J Annu Rev immunol 1996; 14: 649-83.
B and enhances activator
protein-1 binging activity in ischemic rat heart. Surgery 2000; 127: 161-9.
B
collabotate to induce interleukin-6 gene expression and release. J Biol Chem
2000; 275: 23814-24.
B.
Chin Pharmacol Bull 2000; 16: 227-8.
B
during ischemia in perfused rat heart. Am J Physiol 1999; 276 (2 Pt 2): H543-52.
B attenuates proinflammatory
cytokine and inducible nitric-oxide synthase expression in postischemic myocardium.
Biochim Biophys Acta 1998; 1406: 91-106.